Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Equine rhinopneumonitis - influenza vaccine - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Haemophilus influenzae type b-vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Haemophilus influenzae type B (Hib)-/difteri-/tetanus-/kighostevaccine hætteglas + fyldt sprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Haemophilus influenzae type B (Hib)- + difteri- + tetanus- + kighostevaccine i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Haemophilus influenzae type b (Hib)-/difteri-/tetanus-/kighostevaccine hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
influenzavaccine, split virion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
inaktiveret influenzavaccine, overfladeantigen, subunit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Haemophilus influenzae type B-vaccine pulver til injektionsvæske, rekonstitution + solvens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
influenzavaccine, split virion, injektionsvæske, suspension i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
inaktiveret influenzavaccine, overfladeantigen, subuniti fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
influenzavirusvaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Haemophilus influenzae type b-polysaccharidvaccine, konjugeret (difteritoxoidkonjugat) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Haemophilus influenzae type b-oligosaccharidvaccine, konjugeret (difteri CRM>197< proteinkonjugeret) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
svineinfluenzavirusvaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Influenza vaccine injection 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Influenza vaccine prefilled syringe 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Influenza vaccine Vials 5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Influenza vaccine Vials 25mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
influenzavirusvaccine 45 mg injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 7.5ml/5ml (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
inaktiveret influenzavaccine, split virion, i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
inaktiveret influenzavirosomvaccine bestående af overfladeantigen i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Diphtheria and tetanus toxoid 0.5vial/haemophilus b conjugate injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
trivalent influenzavirusvaccine 45 µg/0,5 ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
trivalent influenzavirusvaccine 45 µg/0,5 ml injektionsvæske, opløsning, sprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Influenza vaccine injection 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Influenza vaccine prefilled syringe 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Influenza vaccine Vials 5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Influenza vaccine Vials 25mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
vaccine mod Haemophilus influenzae type B |
Is a |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
inaktiveret influenzavaccine, split virion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Inactivated influenza surface antigen vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
levende influenzavirus-vaccine til intranasal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
levende influenzavirus-vaccine 0,5 ml næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
influenzavaccine, split virion |
Is a |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
influenza-overfladeantigenvaccine |
Is a |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
forgiftning med influenzavaccine |
Causative agent |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
accidentel forgiftning med influenzavaccine |
Causative agent |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
tilsigtet forgiftning med influenzavaccine |
Causative agent |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
forgiftning med influenzavaccine, uvist med hvilken hensigt |
Causative agent |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Allergy to influenza vaccine |
Causative agent |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Animal immunization for influenza |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Administration of influenza vaccine |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Administration of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Administration of fourth dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
inaktiveret influenzavirosomvaccine bestående af overfladeantigen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
inaktiveret influenzavirosomvaccine bestående af overfladeantigen i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Adverse reaction to influenza virus vaccine |
Causative agent |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
vaccine mod influenzavirus H5N1 |
Is a |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
levende influenzavirus-vaccine 0,2 ml næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Product containing Influenza virus vaccine in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Animal immunization for influenza |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Administration of influenza vaccine |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Animal immunization for influenza |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Administration of influenza vaccine |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Influenza A virus subtype H1N1 vaccine |
Is a |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
|
Allergy to influenza vaccine |
Causative agent |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
Administration of influenza vaccine via nasal route |
Direct substance |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
trivalent influenzavirusvaccine 45 µg/0,5 ml injektionsvæske, opløsning, sprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |
trivalent influenzavirusvaccine 45 µg/0,5 ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccine mod influenzavirus |
Inferred relationship |
Some |
1 |